Tenaya Therapeutics Stock Market Value
| TNYA Stock | USD 2.96 0.58 24.37% |
| Symbol | Tenaya |
Tenaya Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tenaya Therapeutics. If investors know Tenaya will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tenaya Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.44) | Return On Assets (0.46) | Return On Equity (0.84) |
The market value of Tenaya Therapeutics is measured differently than its book value, which is the value of Tenaya that is recorded on the company's balance sheet. Investors also form their own opinion of Tenaya Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Tenaya Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tenaya Therapeutics' market value can be influenced by many factors that don't directly affect Tenaya Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tenaya Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tenaya Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tenaya Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Tenaya Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Tenaya Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Tenaya Therapeutics.
| 07/05/2023 |
| 11/26/2024 |
If you would invest 0.00 in Tenaya Therapeutics on July 5, 2023 and sell it all today you would earn a total of 0.00 from holding Tenaya Therapeutics or generate 0.0% return on investment in Tenaya Therapeutics over 510 days. Tenaya Therapeutics is related to or competes with Bicycle Therapeutics, IGM Biosciences, Monte Rosa, Stoke Therapeutics, Biomea Fusion, Akero Therapeutics, and Gossamer Bio. Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the... More
Tenaya Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Tenaya Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Tenaya Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.98 | |||
| Information Ratio | 0.0247 | |||
| Maximum Drawdown | 38.23 | |||
| Value At Risk | (6.88) | |||
| Potential Upside | 12.11 |
Tenaya Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tenaya Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Tenaya Therapeutics' standard deviation. In reality, there are many statistical measures that can use Tenaya Therapeutics historical prices to predict the future Tenaya Therapeutics' volatility.| Risk Adjusted Performance | 0.0411 | |||
| Jensen Alpha | 0.0405 | |||
| Total Risk Alpha | (0.85) | |||
| Sortino Ratio | 0.0369 | |||
| Treynor Ratio | 0.137 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Tenaya Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Tenaya Therapeutics Backtested Returns
Tenaya Therapeutics appears to be unstable, given 3 months investment horizon. Tenaya Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0577, which indicates the firm had a 0.0577% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Tenaya Therapeutics, which you can use to evaluate the volatility of the company. Please review Tenaya Therapeutics' Risk Adjusted Performance of 0.0411, coefficient of variation of 2376.96, and Semi Deviation of 4.77 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Tenaya Therapeutics holds a performance score of 4. The entity has a beta of 2.21, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Tenaya Therapeutics will likely underperform. Please check Tenaya Therapeutics' value at risk, as well as the relationship between the skewness and day median price , to make a quick decision on whether Tenaya Therapeutics' existing price patterns will revert.
Auto-correlation | 0.02 |
Virtually no predictability
Tenaya Therapeutics has virtually no predictability. Overlapping area represents the amount of predictability between Tenaya Therapeutics time series from 5th of July 2023 to 16th of March 2024 and 16th of March 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Tenaya Therapeutics price movement. The serial correlation of 0.02 indicates that only 2.0% of current Tenaya Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.02 | |
| Spearman Rank Test | -0.07 | |
| Residual Average | 0.0 | |
| Price Variance | 1.06 |
Tenaya Therapeutics lagged returns against current returns
Autocorrelation, which is Tenaya Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Tenaya Therapeutics' stock expected returns. We can calculate the autocorrelation of Tenaya Therapeutics returns to help us make a trade decision. For example, suppose you find that Tenaya Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Tenaya Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Tenaya Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Tenaya Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Tenaya Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Tenaya Therapeutics Lagged Returns
When evaluating Tenaya Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Tenaya Therapeutics stock have on its future price. Tenaya Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Tenaya Therapeutics autocorrelation shows the relationship between Tenaya Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Tenaya Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Tenaya Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tenaya Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tenaya Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tenaya Therapeutics Stock:Check out Tenaya Therapeutics Correlation, Tenaya Therapeutics Volatility and Tenaya Therapeutics Alpha and Beta module to complement your research on Tenaya Therapeutics. For information on how to trade Tenaya Stock refer to our How to Trade Tenaya Stock guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Tenaya Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.